Literature DB >> 9619150

Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.

M Yasuda1, E Mori, H Kitagaki, H Yamashita, N Hirono, K Shimada, K Maeda, C Tanaka.   

Abstract

OBJECTIVE: Diffuse brain atrophy is one of the gross pathological features of Alzheimer's disease and is a result of degenerative changes. The epsilon 4 allele of apolipoprotein E (APOE) is a risk factor or susceptibility gene in late-onset sporadic Alzheimer's disease and may influence the pathological changes associated with the disease. The aim of this study was to examine the relationship between the APOE epsilon 4 allele and whole brain atrophy.
METHOD: Whole brain volume was quantified by using high-resolution magnetic resonance imaging and the computerized brain segmentation technique in 178 patients with late-onset sporadic Alzheimer's disease who carried no APOE epsilon 4 alleles (N = 62), one epsilon 4 allele (N = 93), or two (N = 23) and had comparable clinical severity of dementia.
RESULTS: An apparent positive correlation was found between normalized whole brain volume (relative to total intracranial volume) and number of APOE epsilon 4 alleles; i.e., patients carrying two APOE epsilon 4 alleles had the least brain atrophy. This association between the APOE epsilon 4 allele and brain volume was similar in women and men and was independent of age, level of education, duration of illness since symptom onset, and severity of dementia.
CONCLUSIONS: The results indicate that cognitive dysfunction progresses before severe brain atrophy develops in patients carrying the APOE epsilon 4 allele and suggest that an APOE epsilon 4-allele-related mechanism that affects neuronal function before a decrement in brain matter is involved in the development of dementia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619150     DOI: 10.1176/ajp.155.6.779

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

Review 1.  Traumatic brain injury as a risk factor for Alzheimer's disease: a review.

Authors:  T C Lye; E A Shores
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

Review 2.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Authors:  Kejal Kantarci; Clifford R Jack
Journal:  NeuroRx       Date:  2004-04

3.  Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

Authors:  J L Whitwell; W R Crum; H C Watt; N C Fox
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

4.  Brain tissue volumes by APOE genotype and leisure activity-the AGES-Reykjavik Study.

Authors:  Sigridur Harpa Hafsteinsdottir; Gudny Eiriksdottir; Sigurdur Sigurdsson; Thor Aspelund; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason
Journal:  Neurobiol Aging       Date:  2011-08-19       Impact factor: 4.673

Review 5.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

6.  Dementia, quantitative neuroimaging, and apolipoprotein E genotype.

Authors:  E D Bigler; C M Lowry; C V Anderson; S C Johnson; J Terry; M Steed
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

7.  Computer-aided diagnosis with radiogenomics: analysis of the relationship between genotype and morphological changes of the brain magnetic resonance images.

Authors:  Chiharu Kai; Yoshikazu Uchiyama; Junji Shiraishi; Hiroshi Fujita; Kunio Doi
Journal:  Radiol Phys Technol       Date:  2018-05-10

8.  Apolipoproteins E and C1 and brain morphology in memory impaired elders.

Authors:  J M Serra-Grabulosa; P Salgado-Pineda; C Junqué; C Solé-Padullés; P Moral; A López-Alomar; T López; A López-Guillén; N Bargalló; J M Mercader; I C Clemente; D Bartrés-Faz
Journal:  Neurogenetics       Date:  2002-12-21       Impact factor: 2.660

9.  Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.

Authors:  M Pievani; P E Rasser; S Galluzzi; L Benussi; R Ghidoni; F Sabattoli; M Bonetti; G Binetti; P M Thompson; G B Frisoni
Journal:  Neuroimage       Date:  2009-01-21       Impact factor: 6.556

10.  Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study.

Authors:  Robyn A Honea; Eric Vidoni; Amith Harsha; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.